Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|48|1|36-44

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.48, Iss.1, 2018-01, pp. : 36-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of regimens combining direct acting antiviral agents for hepatitis C virus recombinant form RF1_2k/1b

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 3-4

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1040-1048

John Wiley & Sons Inc

Access to resources Recommend Favorite

Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 3, 2018-03 ,pp. : 451-457

John Wiley & Sons Inc

Access to resources Recommend Favorite

P040: Association between Interleukin‐12 receptor B1 gene polymorphism (rs401502 C/G) and chronic Hepatitis B Virus infection

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 39-39

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential Changes of Hepatitis C Virus Antibody Profiles during Treatment of Chronic Hepatitis C of Genotype 1b: Pretreatment Antibody Response to E2/NS1 Correlated Sustained Response

By Chu C.   Sheen I.   Liaw Y.  

Infection, Vol. 32, Iss. 3, 2004-06 ,pp. : 153-156

Springer Publishing Company

Access to resources Recommend Favorite